The Effects of Instructions on Dual-Task Walking and Cognitive Task Performance in People with Parkinson's Disease

Table 1

Individual characteristics and group summary for participants with PD and summary for HOA and HYA groups.

	Age	PD duration	Sex	MDS-UPDRS	H & Y	MoCA	Medications (LED)
PD-101	66	13	M	32	2	29	Carbidopa/levodopa, pramipexole (256)
PD-102	67	7	F	21	2	26	Carbidopa/levodopa, pramipexole, selegiline (204)
PD-103	77	3	M	41	2	27	Carbidopa/levodopa (63)
PD-104	62	17	F	47	2	26	Carbidopa/levodopa, entacapone, amantadine, ropinirole (958)
PD-105	72	6	F	18	3	27	Carbidopa/levodopa, rasagiline (163)
PD-106	66	4	F	9	1	29	Rasagiline, pramipexole (125)
PD-107	78	9	M	31	2	22	Carbidopa/levodopa, pramipexole (525)
PD-108	81	2	M	46	2	27	Carbidopa/levodopa (75)
PD-109	70	7	M	57	2	30	Carbidopa/levodopa, pramipexole (450)
PD-110	70	8	F	18	2	25	Carbidopa/levodopa (200)
PD-111	83	4	M	22	2	29	Carbidopa/levodopa (150)
PD-112	79	6	M	49	3	23	Carbidopa/levodopa, amantadine (425)
PD-113	71	4	M	38	2	28	Ropinirole (160)
PD-114	68	1	M	25	2	29	Selegiline (100)
PD-115	73	1	F	23	3	29	Carbidopa/levodopa (125)
PD; mean (SD); range	72.2 (6.2); 62–83	6.1 (4.4)	6 F/9 M	32 (14); 9–57	2.1 (1.5); 1–3	27.1 (2.3); 22–30	265 (238)
HOA; mean (SD); range	69.2 (7.1); 60–80	—	10 F/5 M	—	—	28.5 (1.7); 24–30	—
HYA; mean (SD); range	26.4 (4.3); 20–36	—	9 F/6 M	—	—	—	—

Age and PD duration in years. MDS-UPDRS: Movement Disorders Society Unified Parkinson’s Disease Rating Scale, motor examination. H & Y: Hoehn and Yahr rating scale. MoCA: Montreal Cognitive Assessment. LED: levodopa equivalent dosage. SD: standard deviation.